Myriad Genetics | MYGN - Sales Revenues


Myriad Genetics reported $209.8M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agilent USD 1.8B 63M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Bio-Rad Laboratories USD 693.2M 40.2M Dec/2025
Bruker USD 977.2M 116.7M Dec/2025
Danaher USD 5.95B 890M Mar/2026
Illumina USD 1.16B 80M Dec/2025
J&J USD 24.1B 500M Mar/2026
Mettler Toledo International USD 1.13B 100M Dec/2025
Myriad Genetics USD 209.8M 4.1M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quest Diagnostics USD 2.9B 90M Mar/2026
Quidel USD 724M 24M Dec/2025
Repligen USD 197.91M 8.91M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Standard Biotools USD 23.8M 4.24M Dec/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Veracyte USD 140.6M 8.7M Dec/2025
Waters USD 932M 132M Dec/2025